Novel Method for Risk Stratification of Major Adverse Clinical Events Using Pre- and Post-Ablation Left Atrial Volume Index in Patients With Persistent Atrial Fibrillation-Reference-Cited by-同舟云学术

Novel Method for Risk Stratification of Major Adverse Clinical Events Using Pre- and Post-Ablation Left Atrial Volume Index in Patients With Persistent Atrial Fibrillation

Published:2024-09-07 Issue: Volume: Page:
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Ishiguchi Hironori¹²,Yoshiga Yasuhiro¹,Shimizu Akihiko³,Fukuda Masakazu¹,Omuro Ayumi¹,Hisaoka Masahiro¹,Nakashima Yusuke¹,Fujita Miho¹,Hashimoto Shintaro¹,Omuro Takuya⁴,Ariyoshi Toru⁵,Kobayashi Shigeki⁶,Okamura Takayuki¹,Sano Motoaki¹

Affiliation:

1. Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine

2. Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital

3. Department of Cardiology, Ube-Kohsan Central Hospital

4. Department of Medicine and Clinical Science, Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine

5. Ultrasound Examination Center, Yamaguchi University Hospital

6. Department of Therapeutic Science for Heart Failure in the Elderly, Yamaguchi University Graduate School of Medicine

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circrep/advpub/0/advpub_CR-24-0062/_pdf

Reference26 articles.

1. 1. Reddy YNV, Obokata M, Verbrugge FH, Lin G, Borlaug BA. Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. J Am Coll Cardiol 2020; 76: 1051–1064.

2. 2. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42: 373–498.

3. 3. Thomas L, Abhayaratna WP. Left atrial reverse remodeling. JACC Cardiovasc Imaging 2017; 10: 65–77.

4. 4. Inciardi RM, Bonelli A, Biering-Sorensen T, Cameli M, Pagnesi M, Lombardi CM, et al. Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: A new target for prevention and treatment. Eur J Heart Fail 2022; 24: 959–975.

5. 5. Andrade JG, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, et al. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med 2023; 388: 105–116.